¶ Vivek Ramaswamy
Vivek Ganapathy Ramaswamy is an American entrepreneur and political candidate. His brother is Shankar Ramaswamy, founder of Kriya Therapeutics.[1]
¶ History
In 2011, Ramaswamy was awarded a post-graduate fellowship by the Paul & Daisy Soros Fellowships for New Americans.[2][3]
Ramaswamy founded Roivant Sciences, incorporated April 7, 2014 in Bermuda.[4][5]
In January 2015, Ramaswamy was named Chairman of Tekmira Pharmaceuticals after it merged with OnCore Biopharma.[6][7]
¶ COVID-19
Ramaswamy stepped down as CEO of Roivant in January 2021.[8]
Ramaswamy has appeared as a guest on The Roundtable Show.[9]
Ramaswamy co-founded Strive Asset Management with Anson Frericks in 2022.[10] The firm launched on May 9, 2022.[11]
As of the end of 2022, Ramaswamy reportedly owned 10.9% of Roivant Sciences.[12] On February 21, 2023, Roivant announced that Ramaswamy had stepped down from the company's board of directors in order to focus on his presidential campaign.[4:1]
¶ External links
Team Archive. Kriya Therapeutics. Retrieved January 5, 2024, from https://web.archive.org/web/20240105214538/https://kriyatherapeutics.com/team/ ↩︎
Novak, M. (2023, March 3). Wikipedia Editor Says They Were Paid To Change Vivek Ramaswamy’s Page. Forbes. http://archive.today/2023.06.25-234951/https://www.forbes.com/sites/mattnovak/2023/05/03/wikipedia-editor-says-they-were-paid-to-change-vivek-ramaswamys-page/?sh=2786e43c51a3 ↩︎
Meet the Fellows | Vivek Ramaswamy. Paul & Daisy Soros Fellowships for New Americans. Retrieved April 25, 2023, from http://archive.today/2023.04.25-063342/https://www.pdsoros.org/meet-the-fellows/vivek-ramaswamy ↩︎
Lee, S. (2023, February 21). Roivant Sciences Announces Change to its Board of Directors. Roivant Sciences. https://web.archive.org/web/20230626001023/https://investor.roivant.com/news-releases/news-release-details/roivant-sciences-announces-change-its-board-directors ↩︎ ↩︎
Bermuda Registrar of Companies. (2017, January 10). Roivant Sciences Ltd. OpenCorporates. http://archive.today/2023.06.26-015348/https://opencorporates.com/companies/bm/48931 ↩︎
Canada’s Tekmira to buy US-based OnCore Biopharma, focus on HBV treatment. (2015, January 12). Reuters. http://archive.today/2023.06.26-001352/https://www.reuters.com/article/oncore-ma-tekmira-idUSL3N0UR1EZ20150112 ↩︎
Rezler, J. P. (2015, March 4). Tekmira Announces Completion of the Merger With OnCore Creating a Leading Hepatitis B Solutions Company. Securities and Exchange Commission. https://web.archive.org/web/20230626001935/https://www.sec.gov/Archives/edgar/data/1447028/000117184315001290/newsrelease.htm ↩︎
Mishra, M., & Samuel, M. (2021, January 25). Roivant Sciences founder to step down as CEO. Reuters. http://archive.today/2023.06.26-002412/https://www.reuters.com/article/us-roivant-ceo-idUSKBN29U1QY ↩︎
Vivek Ramaswamy. The Roundtable Show. Retrieved June 25, 2023, from http://archive.today/2023.06.25-235453/https://roundtable.live/portfolio-archive/vivek-ramaswamy/ ↩︎
Aucamp, E. (2022, November 15). Strive Asset Management Exceeds Half a Billion in AUM, 3 Months After Launch. Yahoo Finance. https://web.archive.org/web/20230625235937/https://ca.finance.yahoo.com/news/strive-asset-management-exceeds-half-180000618.html ↩︎
Marinelli, S. (2022, May 9). Depoliticizing Corporate America: Strive Asset Management Launches To Advance Excellence Capitalism Over “Stakeholder Capitalism.” Business Wire. https://web.archive.org/web/20230322104556/https://www.businesswire.com/news/home/20220509006251/en/Depoliticizing-Corporate-America-Strive-Asset-Management-Launches-To-Advance-Excellence-Capitalism-Over-‘Stakeholder-Capitalism’ ↩︎
Ramaswamy, V. (2023, February 14). Schedule 13G/A. Securities and Exchange Commission. https://web.archive.org/web/20230626014955/https://www.sec.gov/Archives/edgar/data/1635075/000114036123007052/ny20007498x1_sc13ga.htm ↩︎